Is epkinly for lymphoma?

Is Epkinly (epcoritamab) used to treat lymphoma?

Yes. Epkinly (epcoritamab-bysp) is a treatment for certain types of lymphoma, including relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and related aggressive B-cell lymphomas [1].

Which lymphoma types does Epkinly target?

Epkinly is aimed at aggressive B-cell lymphomas that express CD20 and are commonly classified under DLBCL or related categories when they have returned or did not respond to earlier treatment [1].

Is it for Hodgkin lymphoma or non-Hodgkin lymphoma?

Epkinly is used for non-Hodgkin lymphoma (NHL) types, not Hodgkin lymphoma. Its use is tied to aggressive B-cell NHL (including DLBCL) settings rather than Hodgkin lymphoma [1].

What does “for lymphoma” usually mean in practice?

When people say Epkinly is “for lymphoma,” it typically refers to cases where the disease is relapsed (came back) or refractory (didn’t respond well enough to prior therapy), and where the lymphoma fits the indicated aggressive B-cell categories [1].

Sources:
1. https://www.drugpatentwatch.com/epkinly-epcoritamab-bysp-patent/